Stabilising oral poliovaccine at high ambient temperatures.

Dev Biol Stand

Laboratory of Epidemiology and Public Health, Yale University, New Haven, CT, USA.

Published: February 1997

The oral poliovaccine strains lose infectivity when they are stored above refrigerator temperatures. These losses increase rapidly at the high temperatures encountered in tropical countries, thus causing problems if the cold chain is inadequate. Attempts to minimise these losses have generally relied on the addition of salts such as MgCl2. In this paper we show that the fail in infectivity, which is due to the hydrolysis of the genomic RNA by the RNA polymerase within the virus particle, can be greatly inhibited by the suppression of this enzymatic activity. This can be achieved simply by reducing the pH below 7.

Download full-text PDF

Source

Publication Analysis

Top Keywords

oral poliovaccine
8
stabilising oral
4
poliovaccine high
4
high ambient
4
ambient temperatures
4
temperatures oral
4
poliovaccine strains
4
strains lose
4
lose infectivity
4
infectivity stored
4

Similar Publications

The widespread use of the oral poliovaccine from Sabin strains (tOPV) radically reduced poliomyelitis incidence worldwide. However, OPV became a source of neurovirulent vaccine-derived polioviruses (VDPVs). Currently, circulating type 2 VDPVs (cVDPV2) are the leading cause of poliomyelitis.

View Article and Find Full Text PDF

Prevalence and Bayesian Phylogenetics of Enteroviruses Derived From Environmental Surveillance Around Polio Vaccine Switch Period in Shandong Province, China.

Food Environ Virol

December 2020

Department of Epidemiology, School of Public Health, Cheeloo College of Medicine, Shandong University, 44 Wenhuaxi Road, Jinan, 250012, Shandong, China.

We present the results of environmental surveillance for poliovirus (PV) and non-poliovirus (NPEV) around the switch from trivalent to bivalent oral polio-vaccine (OPV) which occurred in China in May 2016. Sewage samples were collected in Jinan and Linyi city from 2015 to 2017. Enterovirus (EV) isolation, VP1 amplification, Sanger sequencing, and phylogenetic analyses were performed.

View Article and Find Full Text PDF

SV40 seroprevalence in two Latin American countries involved in field trials of candidate oral poliovaccines.

J Infect

June 2019

Department of Molecular Virology and Microbiology, Baylor College of Medicine, One Baylor Plaza, MS: BCM385, Houston, TX 77030, USA. Electronic address:

Objectives: This study sought to determine SV40 seroprevalence in residents of two Latin American countries, Colombia and Nicaragua, which were sites of prelicensure oral poliovaccine (OPV) trials.

Methods: Archival sera were tested for SV40 neutralizing antibody using a virus-specific plaque-reduction assay. Samples included 517 sera from Colombia and 149 sera from Nicaragua.

View Article and Find Full Text PDF

Background: Enteroviruses are the most common causative agents of human illness. Enteroviruses have been associated with regional and global epidemics, recently, including with severe disease (Enterovirus A71 and D68), and are of interest as emerging viruses. Here, we typed Enterovirus A-D (EV) from central nervous system (CNS) and respiratory infections in Viet Nam.

View Article and Find Full Text PDF

To investigate the status of immunization of National Immunization Program (NIP) and its adverse reaction rate in children with tuberous sclerosis. Questionnaire survey was adopted to identify the vaccination coverage and its adverse events; 72 cases of children with tuberous sclerosis and 78 normal controls (healthy children completing age-appropriate NIP) admitted to Chinese People's Liberation Army General Hospital from December 2014 to November 2015 were involved into this study. The age-appropriate NIP coverage rate of tuberous sclerosis was 36%(26/72).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!